Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharm...
FDA Recall #D-0391-2025 — Class II — April 18, 2025
Product Description
Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, NDC 68788-8685-03.
Reason for Recall
cGMP Deviations
Recalling Firm
Preferred Pharmaceuticals, Inc. — Anaheim, CA
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
1190 Bottles
Distribution
Nationwide in the US
Code Information
Lot #: L0224T, K1824M, K0124N, J1624V, J0824O, I2424E, I1024O, A0925F, L2324L, Exp: 7/31/2026.
Status
Ongoing
Voluntary / Mandated
Voluntary: Firm initiated